Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Bell

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Medical Education|October 31, 2009
When only the real thing will do: junior medical students' learning from real patientsKathryn Bell, Henny P A Boshuizen, Albert Scherpbier, et al.
Medicine and Science in Sports and Exercise|October 10, 2018
Supplemental Oxygen Does Not Influence Self-selected Work Rate at Moderate AltitudeKirsten A Williams, Kathryn Bell, Robert A Jacobs, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2012
Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammationKatie Ellard, Mihiro Sunose, Kathryn Bell, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|September 21, 2011
Ethical issues in research on sensitive topics: participants' experiences of distress and benefitSuzanne E Decker, Amy E Naugle, Robin Carter-Visscher, et al.
Anatomical Sciences Education|November 10, 2019
Focused Multisensory Anatomy Observation and Drawing for Enhancing Social Learning and Three-Dimensional Spatial UnderstandingLeonard Shapiro, Kathryn Bell, Kallpana Dhas, et al.
Journal of Dental Hygiene : JDH|June 12, 2019
Opinions on Dental Therapists: A comparison of dentists and dental hygienists in the Pacific NorthwestYvette Ly, Elizabeth Schuberg, Janet Lee, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory diseaseMihiro Sunose, Kathryn Bell, Katie Ellard, et al.
Journal of Allied Health|December 6, 2022
Implementation of Virtual Interprofessional Observed Structured Clinical Encounters (OSCEs): A Pilot StudyMónica Sarmiento, Talina Sm Corvus, Matthew Hunsinger, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
SAR studies around a series of triazolopyridines as potent and selective PI3Kγ inhibitorsKathryn Bell, Mihiro Sunose, Katie Ellard, et al.
Gynecologic Oncology|October 20, 2009
Consolidation strategies in ovarian cancer: observations for future clinical trialsPaul Sabbatini, David Spriggs, Carol Aghajanian, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medical Education|October 31, 2009
When only the real thing will do: junior medical students' learning from real patientsKathryn Bell, Henny P A Boshuizen, Albert Scherpbier, et al.
Medicine and Science in Sports and Exercise|October 10, 2018
Supplemental Oxygen Does Not Influence Self-selected Work Rate at Moderate AltitudeKirsten A Williams, Kathryn Bell, Robert A Jacobs, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2012
Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammationKatie Ellard, Mihiro Sunose, Kathryn Bell, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|September 21, 2011
Ethical issues in research on sensitive topics: participants' experiences of distress and benefitSuzanne E Decker, Amy E Naugle, Robin Carter-Visscher, et al.
Anatomical Sciences Education|November 10, 2019
Focused Multisensory Anatomy Observation and Drawing for Enhancing Social Learning and Three-Dimensional Spatial UnderstandingLeonard Shapiro, Kathryn Bell, Kallpana Dhas, et al.
Journal of Dental Hygiene : JDH|June 12, 2019
Opinions on Dental Therapists: A comparison of dentists and dental hygienists in the Pacific NorthwestYvette Ly, Elizabeth Schuberg, Janet Lee, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory diseaseMihiro Sunose, Kathryn Bell, Katie Ellard, et al.
Journal of Allied Health|December 6, 2022
Implementation of Virtual Interprofessional Observed Structured Clinical Encounters (OSCEs): A Pilot StudyMónica Sarmiento, Talina Sm Corvus, Matthew Hunsinger, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
SAR studies around a series of triazolopyridines as potent and selective PI3Kγ inhibitorsKathryn Bell, Mihiro Sunose, Katie Ellard, et al.
Gynecologic Oncology|October 20, 2009
Consolidation strategies in ovarian cancer: observations for future clinical trialsPaul Sabbatini, David Spriggs, Carol Aghajanian, et al.
Pageof 3